Strategic partnerships Leverage Menarini Asia-Pacific’s active collaboration model with global players (e.g., Pharmacosmos, Astellas, Pierre Fabre) to identify co-development, licensing, or distribution opportunities in oncology, rheumatology, dermatology, and anti-infectives across Asia-Pacific.

Portfolio expansion Target opportunities to expand proprietary and partnered brands in key therapeutic areas such as cardio-metabolic, oncology, and allergy/respiratory by offering complementary products, diagnostics, or lifecycle management services to accelerate market access.

Digital and data leverage Capitalize on the tech stack including Power BI and cloud platforms to deliver data-driven value propositions, such as market analytics, real-world evidence generation, and digital marketing solutions for regional launches and post-market surveillance.

Awards and visibility Position offerings around digital innovation, marketing partnerships, and hospital collaborations highlighted by recent Healthcare Asia Pharma Awards to differentiate through enhanced branding, patient access programs, and Key Opinion Leader engagement.

Regional growth focus Align sales efforts with Asia-Pacific market expansion, leveraging Menarini Asia-Pacific’s full value-chain capabilities to propose end-to-end solutions from clinical development to lifecycle management for both proprietary and partnered assets.